A California jury has awarded $332 million to a man who sued chemical giant Monsanto Co. claiming his cancer was related to decades of using the herbicide Roundup.
A San Diego Superior Court jury awarded damages Tuesday in a lawsuit filed by Mike Dennis, 57, of Carlsbad. He was diagnosed in 2020 with a rare form of non-Hodgkin’s lymphoma.
His lawsuit claimed his illness was related to Roundup’s active ingredient, glyphosate.
SOUTHERN CALIFORNIA SCHOOL DISTRICT TO PAY $27 MILLION SETTLEMENT FOR SINGLE STUDENT ASSAULT ALONE
Orange County files lawsuits against Southern California Edison over wildfires
Dennis has had treatment and has been in remission for nearly three years, but there is no cure, Adam Peavy, one of his attorneys, told KNSD-TV.
“The doctors said he’ll be back and we’re just waiting to see if that happens,” Peavy said.
The jury found that Monsanto, which is now a division of the pharmaceutical and biotech giant Bayer, failed to provide warnings about the dangers of Roundup. But the jury also partially ruled in Bayer’s favor, finding that the product’s design was not defective and the company was not negligent.
Dennis was awarded $7 million in compensatory damages and $325 million in punitive damages.
HOMELESS PEOPLE SUE CALIFORNIA AFTER EJECTED FROM PARK AND TRASHED THEIR SERVICES: Lawsuit
In a statement to KNSD-TV, Bayer said it believes “we have strong arguments on appeal to overturn this baseless verdict and eliminate or reduce the unconstitutionally excessive damages.”
“There were significant and reversible legal and evidentiary errors made during this trial,” Bayer added.
Bayer bought Monsanto for $63 billion in 2018 and is trying to deal with thousands of claims and lawsuits related to Roundup. In 2020, Bayer announced it would pay up to $10.9 billion to settle approximately 125,000 filed and unclaimed claims.